Comparison
Omega-3 (DHA/EPA) vs CoQ10
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
CoQ10
Mitochondrial electron-transport cofactor. Naturally declines with age. Ubiquinol form is the active reduced state.
| Field | Omega-3 (DHA/EPA) | CoQ10 |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 100–300mg |
| Half-life | 24h | 33h |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 1700 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and CoQ10 are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. CoQ10 Mitochondrial electron-transport cofactor.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) matches the evidence base of CoQ10 (evidence A, safety 5/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose CoQ10 if
CoQ10 is the better fit when your goal aligns with its mechanism (Cofactor in the mitochondrial electron transport chain at complexes I, II, and III — moves electrons between dehydrogenases and complex III, enabling ATP synthesis) and the dose range (100–300mg) suits your protocol. Half-life is 33h.